BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28174603)

  • 1. MLPA analysis in a cohort of patients with autism.
    Peixoto S; Melo JB; Ferrão J; Pires LM; Lavoura N; Pinto M; Oliveira G; Carreira IM
    Mol Cytogenet; 2017; 10():2. PubMed ID: 28174603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT.
    Cai G; Edelmann L; Goldsmith JE; Cohen N; Nakamine A; Reichert JG; Hoffman EJ; Zurawiecki DM; Silverman JM; Hollander E; Soorya L; Anagnostou E; Betancur C; Buxbaum JD
    BMC Med Genomics; 2008 Oct; 1():50. PubMed ID: 18925931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of selected genomic deletions and duplications in a cohort of 338 patients presenting with syndromic obesity by multiplex ligation-dependent probe amplification using synthetic probes.
    D'Angelo CS; Varela MC; de Castro CIe; Kim CA; Bertola DR; Lourenço CM; Perez AB; Koiffmann CP
    Mol Cytogenet; 2014; 7(1):75. PubMed ID: 25411582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLPA is a practical and complementary alternative to CMA for diagnostic testing in patients with autism spectrum disorders and identifying new candidate CNVs associated with autism.
    Capkova P; Srovnal J; Capkova Z; Staffova K; Becvarova V; Trkova M; Adamova K; Santava A; Curtisova V; Hajduch M; Prochazka M
    PeerJ; 2019; 6():e6183. PubMed ID: 30647996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex ligation-dependent probe amplification as a screening test in children with autism spectrum disorders.
    Łaczmańska I; Stembalska A; Złocińska M; Kozłowska J; Skiba P; Pesz K; Ślęzak R; Śmigiel R; Jakubiak A; Misiak B; Sąsiadek MM
    Adv Clin Exp Med; 2020 Jan; 29(1):101-106. PubMed ID: 31990460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for copy number alterations in loci associated with autism spectrum disorders by two-color multiplex ligation-dependent probe amplification.
    Bremer A; Giacobini M; Nordenskjöld M; Brøndum-Nielsen K; Mansouri M; Dahl N; Anderlid B; Schoumans J
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):280-5. PubMed ID: 19319887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Copy Number Variations in Patients with Autism Using Cytogenetic and MLPA Techniques: Report of 16p13.1p13.3 and 10q26.3 Duplications.
    Ghasemi Firouzabadi S; Vameghi R; Kariminejad R; Darvish H; Banihashemi S; Firouzkouhi Moghaddam M; Jamali P; Farbod Mofidi Tehrani H; Dehghani H; Raeisoon MR; Narooie-Nejad M; Jamshidi J; Tafakhori A; Sadabadi S; Behjati F
    Int J Mol Cell Med; 2016; 5(4):236-245. PubMed ID: 28357200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay.
    Northrop EL; Ren H; Bruno DL; McGhie JD; Coffa J; Schouten J; Choo KH; Slater HR
    Hum Mutat; 2005 Nov; 26(5):477-86. PubMed ID: 16170807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification.
    Procter M; Chou LS; Tang W; Jama M; Mao R
    Clin Chem; 2006 Jul; 52(7):1276-83. PubMed ID: 16690734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA).
    Moelans CB; Atanesyan L; Savola SP; van Diest PJ
    Methods Mol Biol; 2018; 1708():537-549. PubMed ID: 29224162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardation.
    Scott RH; Douglas J; Baskcomb L; Nygren AO; Birch JM; Cole TR; Cormier-Daire V; Eastwood DM; Garcia-Minaur S; Lupunzina P; Tatton-Brown K; Bliek J; Maher ER; Rahman N
    J Med Genet; 2008 Feb; 45(2):106-13. PubMed ID: 18245390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH).
    Alhourani E; Rincic M; Othman MA; Pohle B; Schlie C; Glaser A; Liehr T
    Mol Cytogenet; 2014; 7(1):79. PubMed ID: 25435911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Multiplex Ligation-dependent Probe Amplification (i-MLPA) for rapid copy number variant (CNV) detection.
    Saxena S; Gowdhaman K; Kkani P; Vennapusa B; Rama Subramanian C; Ganesh Kumar S; Mohan KN
    Clin Chim Acta; 2015 Oct; 450():19-24. PubMed ID: 26234520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population.
    Fuka G; Farias-Vieira TM; Hummel L; Blunck CB; Santoro JC; Terra-Granado E; Barbosa TC; Emerenciano M; Pombo-de-Oliveira MS
    Mol Cytogenet; 2015; 8():35. PubMed ID: 26060508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of major genetic alterations in neuroblastoma.
    Costa RA; Seuánez HN
    Mol Biol Rep; 2018 Jun; 45(3):287-295. PubMed ID: 29455316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a simple multiplex ligation-dependent probe amplification (MLPA) assay for rapid detection of copy number variants in the genome.
    Shen Y; Wu BL
    J Genet Genomics; 2009 Apr; 36(4):257-65. PubMed ID: 19376486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
    Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex ligation-dependent probe amplification for rapid detection of proteolipid protein 1 gene duplications and deletions in affected males and carrier females with Pelizaeus-Merzbacher disease.
    Warshawsky I; Chernova OB; Hübner CA; Stindl R; Henneke M; Gal A; Natowicz MR
    Clin Chem; 2006 Jul; 52(7):1267-75. PubMed ID: 16644873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified multiplex ligation-dependent probe amplification method for the detection of 22q11.2 copy number variations in patients with congenital heart disease.
    Zhang X; Xu Y; Liu D; Geng J; Chen S; Jiang Z; Fu Q; Sun K
    BMC Genomics; 2015 May; 16(1):364. PubMed ID: 25952753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.